NCT02356393Completed
Serum Magnesium Levels in Desalination Tap Water and Outcomes in Acute Myocardial Infarction Patients
The Effect of Magnesium Serum Levels on Clinical Outcomes in Patients With Acute Myocardial Infarction by Considering Desalination Drinking Water Levels Patients Fed From.
Source: ClinicalTrials.gov · Last updated 12 Dec 2023
Brief summary (registry, in English)
Association between serum magnesium and clinical outcome in patients with acute MI (AMI) with 1 year follow-up in 300 patients in regions supplied by desalinated drinking water (DSW) (Sheba MC) and 150 patients in regions with non-desalinated drinking water (DW) (Nahariya MC).
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 150 (actual)
- First submitted
- 4 Dec 2014
- Start date
- May 2015
- Primary completion date
- 1 Dec 2023
- Lead sponsor
- Sheba Medical Center
- Diseases
- Heart failure, Coronary artery disease
- NCT number
- NCT02356393
What you commit to
- Study type: Observational
- Participants enrolled: 150
- From May 2015 to the primary completion date, 1 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- 1\. Patients \> age 75
Who the study is looking for
- Patients with first AMI
- Age 35-75
Age in the registry: 35 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Leviev Heart Center, Chaim Sheba Medical Center Coordinator of this site? Confirm its status | Ramat Gan | Israel | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.